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Abstract
The last 100 years have seen a concerning decline in male reproductive health associated with decreased sperm production,
sperm function and male fertility. Concomitantly, the incidence of defects in reproductive development, such as
undescended testes, hypospadias and testicular cancer has increased. Indeed testicular cancer is now recognised as the
most common malignancy in young men. Such cancers develop from the pre-invasive lesion Carcinoma in Situ (CIS), a
dysfunctional precursor germ cell or gonocyte which has failed to successfully differentiate into a spermatogonium. It is
therefore essential to understand the cellular transition from gonocytes to spermatogonia, in order to gain a better
understanding of the aetiology of testicular germ cell tumours. MicroRNA (miRNA) are important regulators of gene
expression in differentiation and development and thus highly likely to play a role in the differentiation of gonocytes. In this
study we have examined the miRNA profiles of highly enriched populations of gonocytes and spermatogonia, using
microarray technology. We identified seven differentially expressed miRNAs between gonocytes and spermatogonia (down-
regulated: miR-293, 291a-5p, 290-5p and 294*, up-regulated: miR-136, 743a and 463*). Target prediction software identified
many potential targets of several differentially expressed miRNA implicated in germ cell development, including members
of the PTEN, and Wnt signalling pathways. These targets converge on the key downstream cell cycle regulator Cyclin D1,
indicating that a unique combination of male germ cell miRNAs coordinate the differentiation and maintenance of
pluripotency in germ cells.
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Introduction
Over the last 100 years there has been a substantial increase in
diseases of the male reproductive system including developmental
abnormalities, poor semen quality and testicular cancer, especially
in developed countries [1–3]. The rising incidence of type II
testicular cancer is highly correlated with infertility as well as more
overt problems of reproductive health suggesting that it is an
indicator of a broader problem with the general reproductive
health of the population [4]. There is concern that exposure to
environmental toxicants in utero, especially endocrine disruptors,
augments a genetic predisposition for testicular germ cell tumours
such as defects in kit signalling (KITLG itself and SPRY an
inhibitor of kit stimulated MAPK signalling), apoptosis (BAK), sex
determination (DMRT1) and telomere regulation (TERT) [5,6].
This is particularly pertinent given that the gonocyte-to-spermato-
gonia transition occurs in late gestation in humans [7] and that
Carcinoma in Situ (CIS) cells have previously been identified as
arising from arrested/dysfunctional gonocytes [8]. Taken together
these findings suggest that the risk for testicular cancer must
therefore be established in utero.
MicroRNAs (miRNA) are short untranslated RNA molecules
which bind to and post-transcriptionally regulate mRNA expres-
sion. Since their discovery in 1993, they have been found to be
essential regulatory molecules in many developmental and cell
signalling pathways [9]. Although some miRNA are ubiquitously
expressed, the majority of miRNA species are expressed in a tissue
specific manner [10,11]. MicroRNA molecules are produced by
an endonuclease Dicer, associate with a protein complex (RISC) in
the cytoplasm, and target mRNA molecules by complementary
base pairing, usually in the 39UTR. Binding of the RISC complex
to mRNA causes transcript degradation, mRNA sequestering or
inhibition of translation [9]. In contrast, when the cell cycle is
arrested, miRNA can promote the translation of mRNAs
containing AU rich elements [12]. A study of 130 non-redundant
proteins in Sertoli cell-specific Dicer knockout mice, demonstrated
that 50 proteins were up-regulated and three proteins were down-
regulated, indicating that miRNA are primarily involved in the
inhibition of protein translation [13].
After primordial germ cells are specified in early embryogenesis
they migrate through the hindgut to reach the genital ridges,
where they are termed gonocytes. Within the gonads gonocytes
undergo sex specific differentiation to become prospermatogonia
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prospermatogia (gonocytes) migrate to the basement membrane of
the seminiferous tubules and differentiate into spermatogonia [16].
When perturbed this can result in the specification of CIS cells
instead of prospermatogonia [7,8]. After puberty spermatogonial
stem cells maintain an undifferentiated population while specifying
some daughter cells to undergo the process of spermatogenesis to
produce sperm. Differentiating spermatogonia undergo transiently
amplify their numbers by mitosis before becoming type B
spermatogonia which divide by meiosis to become spermatocytes.
Spermatocytes divide again without replicating their DNA to
become haploid spermatids, which differentiate in a process
known as spermiogenesis to become mature spermatozoa [15].
Spermatogenesis involves many unique genes [17], the
expression of which are translationally uncoupled from protein
production in germ cell development, a process thought to be
partially coordinated via miRNA suppression [13]. The regulation
of genes involved in meiosis and spermatid differentiation by
miRNA has been found to be essential for functional spermato-
genesis [18–20]. Interestingly the miRNA testis expression profile
is unique; for example, Linsen et al [11] found fewer miRNA in rat
testis tissue than in the other tissues studied, yet 35 of these were
specific to the testis. In a cloning study, Ro et al [21] identified 141
miRNA expressed in mouse testis, of which 35% were preferen-
tially expressed in the testis and 5% were unique to the testis.
Aberrant expression of miRNA molecules and mutations in
their recognition sites on mRNA are associated with infertility in
men [22,23]. Of particular note the oncogenic miR-17-92 as well
as the oncogenic cluster linked to testicular cancer, miR-371-373,
were down-regulated in infertile men. It is proposed that the lack
of protection against apoptosis provided by these miRNAs caused
developing germ cells to die before differentiating into spermato-
zoa [23]. Furthermore, studies in the mouse [24] and chicken [25]
have demonstrated changes in miRNA expression after exposure
to toxins. Oncogenic miRNAs including miR-17-20 tended to be
up-regulated after xenobiotic exposure while tumour suppressor
miRNAs such as let-7, tended to be down-regulated [24].
Therefore it is highly probable miRNA play a key role in the
response to toxic challenge in many different organs of the body,
and could in fact contribute to the development of testicular
cancer following exposure to environmental toxicants in utero.I n
proliferating cells miRNA perform key regulatory roles by either
promoting or inhibiting the cell cycle and safeguard organismal
integrity by inducing apoptosis following DNA damage. For
example, the well-known tumour suppressor p53, activates the
miR-34 family, which in turn halts cell proliferation and arrests
adhesion independent growth in cancer cell lines [26]. E2F1 which
promotes cell cycle progression, while also inducing apoptosis in
damaged cells, positively regulates miR-449a and 449b expression.
miR-449a has been found in high levels in the normal testis but is
absent in testicular tumours. Also miR449a/b promotes apoptosis
in a p53 independent manner in tumour cell lines, indicating this
miRNA family are also key regulators of apoptosis [27]. Type II
testicular germ cell tumours develop from transformed gonocytes
(CIS) which proliferate and become neoplastic after puberty
[8,28]. Expression profiling of miRNA in testicular germ cell
tumours has identified several key miRNA molecules which allow
germ cell tumours to bypass traditional mechanisms of cancer
development [29]. Gillis et al [30] profiled the expression of type I,
II and III testicular germ cell tumours and identified some miRNA
species as tumour specific.
Studies on conditional germ cell Dicer knockout mice indicate
that miRNA are essential for the formation and maintenance of
spermatozoa, as without Dicer spermatogenesis stalled just before
the elongating spermatid stage [18,19]. In particular, miRNA
regulation of protamination is essential for functional spermato-
genesis [31,32]. Importantly, the expression pattern of miRNAs
changes in germ cells during development, indicating that
miRNAs are likely to play a regulatory role in differentiation
[33–35].
Despite their importance for spermatogenesis, global miRNA
expression studies focussing on crucial stages of germ cell
development have been limited, especially in isolated cells types
[15]. The cloning study previously described [21] further
examined the expression of 28 miRNA molecules they found to
be testis specific in Sertoli cells and isolated germ cells at five
different developmental stages; spermatogonia, pachytene sper-
matocyte, round spermatid, elongating spermatid and spermato-
zoa. Another study concentrated on enriched meiotic germ cells
finding that these cells have the highest concentration of miRNA
of the germ cells within the testis, but unfortunately this study
suffered from problems with contamination [36]. More recently
several additional novel miRNA species and splice variants have
been identified within the testis, further indicating the testis has a
unique miRNA expression profile [37,38].
To date there has been no study on global expression of miRNA
in isolated germ cells during the gonocyte to spermatogonial
transition. This particular developmental stage is of interest given
that the pre-invasive stage of testicular germ cell tumours, CIS, are
derived from a population of dysfunctional gonocytes [8]. To
address this we have examined the global change(s) in expression
between enriched populations of murine gonocytes and spermato-
gonia. Only a few miRNA molecules were expressed at
significantly different levels between gonocytes and spermatogo-
nia, indicating that small changes in the miRNA expression
between cell types can lead to significant changes in the proteomic
profile of these cells. These miRNA molecules have the potential
to regulate many signalling pathways though the regulation of
their target mRNA molecules, such as key signalling molecules
such as hormone receptors, second messengers such as AKT,
ERK and MEK, as well as transcription factors including the
SOX proteins. A number of potential targets of the differentially
expressed miRNA molecules play a role in PTEN and WNT
signalling pathways, both of which have been previously found to
be important in spermatogenesis as well as tumour development.
Materials and Methods
Animals and reagents
Ethics Statement. The use of animals for this study was
approved, and animals maintained and euthanised in accordance
with directions prescribed by the University of Newcastle Animal
Care and Ethics Committee (ACEC) (approval number A-2010-
146).
All chemicals, and reagents were obtained from either Sigma
(Sigma-Aldrich, St. Louis, MO, USA), Research Organics
(Research Organics Inc., Cleveland, OH, USA), Promega
(Promega, Madison, WI, USA), or Invitrogen (Invitrogen
Corporation Carlsbad, CA, USA) unless otherwise stated.
Antibodies were purchased from Abcam (Cambridge, MA,
USA): anti-SOX2 (ab42635), anti-SOX11 (ab59776), anti-FZD4
(ab83042), anti-FZD7 (ab51049), anti-AKT1/2 (ab8933), anti-
Cyclin D1 (ab16663), anti-UCHL1 (ab10404), anti-OCT3/4
(ab27985); Santa Cruz Biotechnology (Santa Cruz, CA, USA):
anti-PTEN (sc7974), anti-SMAD4 (sc7154); Biocore (Sydney,
NSW, Australia): anti-BMPR1a (ap2004b); Calbiochem (Merck
KGaA, Darmstadt, Germany): anti-PLZF (op128); or Sigma: anti-
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(T5168).
Germ cell isolation and characterisation
Gonocytes and spermatogonia were isolated from postnatal day
one and day 7–9 Swiss male mice respectively. Whole testes were
enzymatically dissociated and separated on a 2–4% continuous
bovine serum albumin (BSA) gradient, as previously described
[39]. Germ cell enrichment (.95%) was assessed by immunocy-
tochemistry with germ/pluripotency/stem cell marker(s) PLZF
(Promyelocytic Leukaemia Zinc Finger Protein), UCHL1 (ubiqui-
tin carboxyl-terminal esterase L1), and OCT 3/4 (POU5F1, POU
domain, class 5, transcription factor 1) (Fig. 1) [40,41]. Briefly, cells
were dried on multiwell slides (10,000 cells per well) and stored at
220uC until utilised. In preparation for probing with germ cell
markers, the slides were thawed then rinsed in PBST (PBS, 0.1%
Tween (Astral Scientific, Caringbah, NSW, Australia) before being
blocked and the cells permeabilised with 1% BSA in PBSTx (PBS,
0.025% Triton X100) for 1 hour at room temperature. Cells were
probed with the primary antibody overnight at 4uC (see Table S1
for antibody concentrations), then washed before the appropriate
Alexa Fluor 594-conjugated fluorescent secondary antibody
(Invitrogen) was applied for 1 hour at room temperature. The
cells were washed and counterstained with 49,6-diamidino-2-
phenylindole (DAPI) (Invitrogen) before being mounted with anti-
fade medium (Mowiol 4–88) and viewed on an Axio Imager A1
microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY.
USA) equipped with epifluorescent optics and images captured
with an Olympus DP70 microscope camera (Olympus America,
Centre Valley PA. USA). Upon confirmation of target cell
enrichment, populations of isolated spermatogonial cells were
then either subjected to RNA or protein isolation as described
below.
Total RNA isolation and miRNA microarray analysis
RNA was extracted with phenol/chloroform as previously
described [39] and incubated with 1%DNase (Promega), in
accordance with the manufacturer’s directions, to remove genomic
DNA contamination. Total RNA (1.2 mg) was amplified and
labelled for hybridization to the bead array matrix according to
the manufacturer’s instructions (Illumina, San Diego, CA, USA).
All samples were analysed in biological triplicates. The array
platform was the Illumina mouse miRNA microarray (using the
version 1 revision 2 microRNA assay pool) covering 96% of the
murine miRNA species described in the mirBase database release
12. The data was background subtracted and normalised against
the mean of small nuclear RNA (snoRNA) 142 and snoRNA 234-
1 using BeadStudio (version 3.0) software (Illumina). The miRNAs
were listed according their relative abundance and the fold change
between gonocytes and spermatogonia (Tables S2 and S3). The
expression of each miRNA was clustered (Cluster3, Stanford
University, Palo Alto, CA, USA [42]) and examined using
heatmaps (Java Treeview, Stanford University, Palo Alto, CA,
USA [43]) to visualise trends in miRNA expression in developing
germ cells. Expression analysis was then undertaken with
Significance Analysis of Microarrays (SAM) statistical software
(academic version 2.23 http://www-stat.stanford.edu/_tibs/
SAM/ [44]). SAM expression analysis was performed with a
two-class unpaired Wilcoxon test on unlogged data using 500
permutations. Significant miRNA species had a q-value,4 (false
discovery rate ,4%). The array data described above has been
deposited in the NCBI’s Gene Expression Omnibus (GSE36566).
Reverse transcription of miRNA and mRNA and qRT-PCR
For miRNA, 500 ng of total RNA was reverse transcribed with
specific primers (Sigma) (1 mM), one control (U6) and 2 targets per
reaction, and Superscript II (Invitrogen) according to the
manufacturer’s instructions. For mRNA, 3 mg of total RNA was
reverse transcribed with oligo dT primers and reverse transcriptase
(Promega) according to the manufacturer’s instructions.
RT-PCRs were performed as previously described [39]. cDNA
was amplified with GoTaq qPCR Master Mix (Promega), or
26SYBRH GreenER
TM qPCR SuperMix Universal (AB Gene,
(Thermo Scientific, Rockford, IL, USA)) according to the
manufacturer’s protocol and amplification was conducted using
an MJ Opticon 2 real time thermocycler (Bio-Rad, Hercules, CA,
USA). The forward primers were used in conjunction with m13F
to amplify the cDNA during a PCR reaction. Each PCR was
performed on at least five separate cell isolations in the case of
miRNA reactions and three cell isolations for mRNA reactions.
qPCR data is shown as the average relative gene expression in
spermatogonia compared to gonocytes using the 2e-DDCT
calculation as described previously [45]. In order to eliminate
variation in the concentration of RNA used for the RT-reaction all
PCR reactions were normalised to either small nuclear RNA6
(miRNA samples) or cyclophilin (mRNA samples).
To amplify the miRNA of interest specific primers were
designed with the reverse primer consisting of the last 8
nucleotides in reverse complement of the miRNA sequence
followed by the m13F sequence. This primer was used in the
first strand synthesis during the RT reaction. The forward primer
was the remainder of the miRNA sequence. In instances when the
melting temperature of the forward primer was less than 50uC, the
sequence was modified to include locked nucleic acids (Gene-
Works, Hindmarsh, SA, Australia) to raise the melting tempera-
ture to at least 50uC. The forward primers were used in
conjunction with m13F to amplify the cDNA during a PCR
reaction. The blast function in the miRBase database was used to
check primer specificity and providing the forward or reverse
primer were specific they were considered valid for use. For the
mRNA qRT-PCR reactions a list of the specific primers is
included in the supplementary material (Table S4).
miRNA target prediction and pathway identification
To obtain the most complete list of targets for the miRNA
molecules of interest as well as limit the number of false positives
we took advantage of the feature in the miRWalk database
(http://www.ma.uni-heidelberg.de/apps/zmf/mirwalk/) that al-
lows simultaneous searches of several databases [46]. We
interrogated the following seven databases; miRanda, MiRDB,
MiRWalk, PITA, RNA22, RNAhybrid and Targetscan. When
four or more of these programs co-identified a specific transcript,
then the target(s) were selected for our list of potential targets for
closer examination. In addition, due to the limited ability of all
algorithms to predict targets of miRNA complementary strands (*)
these miRNA* targets were identified using miRWalk and
MiRanda and only those targets predicted by both programs
were examined more closely (Table S5). To gain a better
understanding of the function of the up and down-regulated
miRNAs they were co-analysed with Ingenuity Pathway Analysis
version 8.8 (IPA, Ingenuity Systems, Redwood City, CA, USA) to
identify the key effected pathways. Individual miRNA species
analysis can be found in the supplementary materials (Figure S1).
Protein extraction and Western blotting
Protein was extracted using 300 ml SDS lysis buffer (0.1% SDS,
375 mM Tris, pH 6.8, 1% sucrose), supplemented with a protease
miRNA and Male Germ Cell Differentiation
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per 5 mg of cells or tissue. Protein concentration was estimated
using a Pierce BCA Protein Assay Kit (Thermo Scientific,
Rockford, IL, USA). SDS-PAGE and immunoblotting was
conducted as previously described [39]. Membranes were
‘‘stripped’’ of primary and secondary antibodies using Western
Re-Probe (G-Biosciences), according to the manufacturer’s
instructions and reprobed with anti-a-tubulin to confirm equal
loading. Labelled proteins were detected with either ECL or ECL
Plus Western blotting detection reagents according to the
manufacturer’s instructions (GE Healthcare, Buckinghamshire,
UK). Densitometry was used to determine changes in protein
expression in spermatogonia relative to gonocytes in two pooled
samples by normalising against the loading control of a-tubulin.
Using this system, higher expression in spermatogonia is indicated
by a number greater than 1 while lower expression in the
spermatogonia samples is indicated by a number less than 1.
Immunohistochemistry
Tissue was fixed for 4 h in Bouin’s fixative before being paraffin
embedded and sectioned (4 mm). Slides were dewaxed and
rehydrated before heat activated antigen retrieval in TE buffer
(10 mM Tris, 1 mM EDTA) was performed. Slides were allowed to
cool before being blocked (3% BSA in PBST) for 1 hour. Sections
were probed with an appropriate primary antibody overnight at 4uC
(Table S1), then washed before an Alexa Fluor 594-conjugated
secondary antibody (Invitrogen) was applied for 1 hour at room
temperature. The slides were washed and counterstained with DAPI
before being mounted with anti-fade medium (Mowiol 4–88, Sigma)
and viewed using epifluorescent microscopy as described above.
Results
Characterisation of enriched germ cell populations
At birth, mouse gonocytes are located in the centre of
the seminiferous tubules. However, once differentiation into
Figure 1. Characterisation of isolated gonocyte and spermatogonia cells. Haematoxylin and eosin stained two day old testis section (1A)
demonstrates that gonocytes are found in the centre of the seminiferous tubules of mice. Gonocytes differentiate and migrate to the basement
membrane of the seminiferous tubules where they become established in their niche and begin the process of spermatogenesis as seen in the eight
day old testis section stained with haematoxylin and eosin (1B). C) Total RNA from isolated germ cell populations (three biological replicates) reverse
transcribed and subjected to qPCR. It was found that the gene expression of the germ cell markers Oct3/4 and Ngn3 were significantly higher
(p,0.05) in spermatogonia, twice and four times the amount of gonocytes respectively. The gene expression of the ES cell markers Nanog and PLZF
was significantly lower (p,0.05 and 0.001) in spermatogonia. Isolated gonocytes (D,E,F) and spermatogonia (G,H,I) were fixed on slides and stained
with germ cell markers. 95% of both gonocytes (1D) and spermatogonia (1G) expressed oct4, while less than 5% of gonocytes (1E) and
spermatogonia (1H) expressed PLZF. UCHL1 was expressed in over 95% of gonocytes (1F) and spermatogonia (1I). The expression of PLZF, OCT3/4
and UCHL1 are consistent with previous reports for germ cells indicating our isolated cell populations contained 95% germ cells.
doi:10.1371/journal.pone.0035553.g001
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at the basement membrane (Fig. 1A), where they become
established in their niche - thus allowing them to commence the
process of spermatogonial division and differentiation, see
postnatal day 8 (Fig. 1B). In order to interrogate the changes in
miRNA expression between gonocytes and spermatogonia, these
cell populations were isolated and confirmed as germ cells. For this
purpose, the unique cell populations were separated using an
established BSA gradient sedimentation technique [39] and then
examined for the expression of several germ cell markers. Analysis
with qRT-PCR revealed a number of significant differences in the
expression germ/pluripotency/stem cell markers, including Oct3/
4 (pluripotency marker) and Ngn3 (early differentiating germ cell
marker [47]) which were up-regulated in the spermatogonia cell
population and, Nanog and Plzf (stem cell markers) which were
down-regulated in the spermatogonia cell population (Fig. 1C).
This serves to illustrate that a degree differentiation has occurred
between day 1 and day 7–9 germ cells. At the protein level over
95% of the total cell population in both the gonocyte and
spermatogonial cell enriched fractions were shown to express the
pluripotency marker OCT3/4 (Fig. 1D, 1G), while only 3–6% of
the cell population expressed the stem cell marker PLZF (Fig. 1E,
1H). Finally over 95% of the cell populations expressed the
undifferentiated germ cell marker UCHL1 [41] (Fig. 1F, 1I)
indicating a highly enriched germ cell population within these
samples.
Microarray and qPCR analysis of enriched germ cell
populations
On verification of a highly enriched population of germ cells, we
characterised the differences in miRNA expression between
gonocytes and spermatogonia. For this purpose, total RNA was
extracted from gonocyte and spermatogonial cell populations
(n=3 biological samples) and hybridised to a mouse Illumina bead
microarray as outlined in the materials and methods. The array
data was normalised and the miRNA molecules ranked according
to their expression (Table S2), and fold change, from gonocytes to
spermatogonia (Table S3). However, to discover miRNA with
significantly different expression profiles between these cell
populations, SAM statistical software was utilised. This program
identified three significantly up-regulated (miR-136, 743a and
463* (q-value%=3.811) and four significantly down-regulated
miRNA species (MiR-293, 291a-5p, 290-5p and 294* q-
value%=0) between gonocytes and spermatogonia (Fig. 2A).
The expression of these miRNA molecules was examined in the
individual biological samples using a heat map (Fig. 2B).
Notwithstanding some variation between the biological samples,
this approach confirmed that these miRNA molecules were
differentially expressed between gonocytes and spermatogonia.
The expression of the seven miRNA molecules identified by
SAM was further validated through use of qPCR across five
biological samples. As anticipated, this analysis confirmed that
each of the seven target miRNAs were indeed differentially
expressed between the two cell types. The down-regulated miRNA
molecules, miR-293, 291a-5p, 290-5p and 294* were each
expressed at levels that were approximately five fold lower in
spermatogonia compared to gonocytes (p,0.0001) (Fig. 3A).
Although the up-regulated targets were also confirmed as
significant, the relative fold change in expression of these
individual miRNA species varied dramatically. In this regard,
miR-136 was expressed in spermatogonia at approximately twice
the level it was detected in gonocytes (p,0.001), while miR-743a
exhibited a fourfold change (p,0.0001) and miR-463* was
elevated to approximately 50 fold the levels observed in gonocytes
(p,0.01) (Figure 3B). In the case of miR-463* absolute expression
was low resulting in greater variation when expressed in relative
terms, although the differences were significant.
Identification and characterisation of targets of
significant miRNA
Having identified significant changes in the miRNA expression
profile between gonocytes and spermatogonia, we sought to
determine the functional significance of each of the seven miRNA
species. As described in materials and methods, targets predicted
by multiple software programs were selected for further investi-
gation. Lists of targets for each individual miRNA molecule can be
found in the supplementary material (Table S5). Among the large
number of putative targets identified by this approach, a number
were selected for closer examination on the basis of established
roles in spermatogenesis, carcinogenesis, key cell signalling
pathways or stem cell maintenance. These included Pten (Phosphate
and Tensin Homolog), Sox2 (Sex Determining Region Y Box 2), Sox11 (Sex
Determining Region Y Box 11), Fzd4 (Frizzled Receptor 4) and Fzd7
(Frizzled Receptor 7), Bmpr1a (Bone Morphogenetic Protein Receptor Type
1a), Smad4 (Sterile Alpha Motif Domain Containing 4), Mek (MAP kinase
kinase), Erk (MAP kinase) and Akt. The expression of the majority of
these candidate targets mRNA’s was examined by qPCR (Fig. 4A)
in three biological samples. We determined that the expression of
Fzd4, Fzd7, Pten, and Akt mRNA, with the exception of Fzd7, all
targets of significantly down-regulated miRNAs, did not change
appreciably during the differentiation of gonocytes into spermato-
gonia. The mRNA expression of Bmpr1a (p=0.0012), Sox2
(p,0.0001), Sox11 (p=0.0012) and Smad4 (p,0.0001), with the
exception of Sox2, all targets of significantly up up-regulated
miRNAs, were significantly down-regulated in spermatogonia,
suggesting that they may be the target of miRNA mediated
transcript degradation. However, given that regulation of gene
expression by miRNA can also affect mRNA translation, we also
examined the protein expression levels targets in gonocytes and
spermatogonia via immunoblotting (Fig. 4B). Using densitometric
analysis in duplicate to normalise for protein loading (Fig. 4C), it
was determined that the SOX11 protein was expressed at much
lower levels in spermatogonia (0.26 times) than in gonocytes. This
matches the expression seen in the mRNA analysis. In accordance
with the quantitation of mRNA, but to a lesser degree, the protein
expression of BMPR1a (0.67 times) and SMAD4 (0.74 times) was
lower in spermatogonia than gonocytes. SOX2 protein was
expressed at equivalent levels between gonocytes and spermato-
gonia, in contrast to the declining transcript expression in
spermatogonia in the qPCR analysis (Fig. 4A). The disparity
between the PTEN transcript and protein expression was
attributed to decreased translational repression by miRNAs
occurring in spermatogonia, causing higher expression levels to
occur (1.87 times). Similarly, post-transcriptional control may
contribute to the observed elevation in FZD7 (3.34 times) and
FZD4 (1.25 times) protein expression in spermatogonia compared
to gonocytes. The protein expression of AKT was similar between
gonocytes and spermatogonia, and corresponded to the observed
transcript levels. Two further downstream targets were examined
and protein expression of ERK1/2 (0.71 times) and MEK1/2
(0.83 times) were also found to be slightly lower in spermatogonia
than gonocytes.
After determining that a number of key signalling molecules
change significantly during gonocyte differentiation, we sought to
determine which pathways had the potential to be most influenced
by the seven miRNA molecules identified previously. This analysis
was conducted by combining all of the potential targets of the up
and down-regulated miRNAs (as identified by miRWalk) into two
miRNA and Male Germ Cell Differentiation
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35553Figure 2. Data analysis of the miRNA microarray. Total RNA was isolated from gonocytes and spermatogonia (three biological replicates) and
analysed using the Illumina mouse miRNA microarray (version 1 revision 2). A) Significance Analysis of Microarrays (SAM) statistical software output
(academic version 2.23 http://www-stat.stanford.edu/_tibs/SAM/) [44] was used to identify significantly different miRNA molecules between
gonocytes and spermatogonia. SAM expression analysis was performed with a two-class unpaired Wilcoxon test on unlogged data using 500
miRNA and Male Germ Cell Differentiation
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35553lists, which were used to interrogate the Ingenuity Pathway
Analysis software to identify the pathways containing the most
targets. The list of each miRNAs potential targets was also
examined separately (Fig. S1). Within the top 15 pathways
targeted by the miRNA which are down-regulated in spermato-
gonia (Fig. S2A) were several cancer metabolism pathways and
immune regulatory pathways, and included both the PTEN and
Wnt/b-catenin signalling pathways. Several similar pathways were
also found in the top 15 molecular pathways targeted by up-
regulated miRNAs (Fig. S2B), including the molecular mecha-
nisms of cancer and the PTEN signalling pathway. Other key
pathways include immune regulation, metabolism, and retinoic
acid receptor activation. Given that several of the identified
protein targets are involved in the Wnt/b-catenin signalling
pathway (Fig. 5) and/or the PTEN signalling pathway (Fig. 6) we
elected to focus on these pathways and their potential to be
regulated by our target miRNAs.
In Figure 5 the Wnt/b-catenin pathway is presented in full, with
the members targeted by miRNAs indicated in the adjacent text
with down-regulated miRNA molecules (in spermatogonia) in
green and those up-regulated in red. Some members of the Wnt/
b-catenin signalling pathway which are differentially expressed
between gonocytes and spermatogonia such as the SOX proteins
(see Fig. 4) are highlighted within this pathway, with down-
regulated members green, up-regulated in red and those whose
expression remained unchanged in yellow.
The possibility of miRNA regulation at multiple distinct points
in the signalling cascade of the PTEN signalling pathway is high as
is demonstrated in Figure 6, where predicted miRNA target(s) are
shown. Several members of the PTEN pathway were differentially
expressed between gonocytes and spermatogonia (see Fig. 4) and
these are highlighted within the pathway, as described above for
the Wnt/b-catenin signalling pathway.
In terms of the Wnt/b-catenin pathway (Fig. 5) there are a
number of potential candidates that may be suppressed and/or
activated by our target miRNAs. A key downstream target of this
pathway that may be indirectly regulated by the differentially
expressed miRNA identified in this study is Cyclin D1. Indeed, the
positive regulator of Cyclin D1 within the PTEN pathway (Fig. 6),
ERK1/2, was targeted by miR-136 (up-regulated molecule) while
the negative regulator, GSK3, was targeted by miR-291a-5p
(down-regulated molecule). On the basis of these findings we
examined the expression of Cyclin D1 mRNA and protein in
gonocytes and spermatogonia using qPCR, immunoblotting and
immunohistochemistry (Fig. 7). These analyses revealed that
Cyclin D1 was expressed in spermatogonia at much higher levels
than in gonocytes. Cyclin D1 transcript expression was approx-
imately six fold higher in spermatogonia than that of gonocytes
(Fig. 7A). Consistent with such findings, Cyclin D1 protein was
undetectable in gonocytes (Fig. 7B,C). It was however clearly
detected in cell lysates prepared from spermatogonia and was
localised to the nucleus of these cells. These data support the
notion that Cyclin D1 is involved in the differentiation of
gonocytes and/or the proliferation of spermatogonia and afford
proof of principle that differential miRNA expression may be a key
regulator of these important processes.
Discussion
In our study of differentially expressed miRNA all the
significantly down-regulated miRNA molecules i.e. miR-293,
291a-5p, 290-5p and 294* belong to the miR-290-295 cluster
and have previously been found to be highly enriched in the germ
cell population of day 6 testis when compared to the somatic cell
population [48]. Additionally, the miR-290-295 cluster is highly
expressed in mouse embryonic stem cells [49], with a role in
promoting cell proliferation and maintaining pluripotency. This
cluster is a target of pluripotency factors, and in turn targets the
pluripotency factors OCT4, SOX2 and NANOG [49–51]. The
artificial expression of members of the miR-290 cluster (291a-3p,
294 and 295) restores the proliferation potential of ES cells lacking
members of the miRNA processing machinery. These ES cells
have a tendency to stall in the G1 stage of the cell cycle [52]. More
recently the miR-290 cluster has been found to have a pro-survival
role by directly targeting pro-apoptosis genes, Caspase2 and Ei24
for mRNA degradation [49]. The expression of the miR-290
cluster is high in multipotent adult germ cells, which are
established upon culture of spermatogonial stem cells under ES
cell conditions. We propose that the elevated expression of the
miR-290 cluster maintains the expression of the pluripotency
factor OCT4, and promotes the expression of early germ cell
specific proteins in these cells for an extended period when
compared to ES cells stimulated to differentiate [50,53].
Additionally, knockout of the miR-290 cluster, besides inducing
a partially penetrant embryonic lethality, leads to the defective
migration of primordial germ cells to the genital ridges during
development, resulting in reduced germ cell numbers in the
nascent gonads. Male germ cells recovered their numbers by
mitotic proliferation while female germ cells were unable to do this
causing infertility in the surviving female knockouts [51]. The
reduction in the expression of the members of the miR-290 cluster
in our spermatogonial analysis, we believe, indicates that these
cells have initiated the process of differentiation i.e. spermatogen-
esis.
In contrast, little is known about the three miRNAs (miR-136,
miR-743a and miR-463*) up-regulated in spermatogonia and
their role in germ cell development remains unclear. The miR-136
has been found to be highly expressed in placental tissue as well as
overexpressed in lung cancer, however knockdown has no effect
on tumour growth, and its function has still not been elucidated
[54,55]. Conversely miR-743a has been identified to play a role in
the oxidative stress response in mitochondria [56]. The above
miRNAs are only slightly enriched in germ cells (miR-743a and
463*) or preferentially expressed in the somatic tissue (miR-136) of
day 6 testis [48] indicating that these miRNA molecules may play
a role in the differentiation process and not in maintaining
pluripotency.
One pathway identified in spermatogonia by our bioinformatic
analysis (Fig. S2) as containing a significant number of differen-
tially expressed miRNA targets was the Wnt signalling pathway
(Fig. 5). Wnt signalling has been shown to play a role in both stem
cell renewal and differentiation in response to differing signals
from surrounding niche cells [57]. Wnt signalling also participates
in the maintenance of the undifferentiated spermatogonial cell
population and promoting their proliferation [57]. Treatment of
permutations. Significant miRNA species had a q-value,4 (false discovery rate ,4%). Seven miRNA molecules were identified by SAM; 3 were up-
regulated in spermatogonia (red) while 4 were down-regulated (green). B) The expression of the significant miRNAs in the individual replicates used
for the array was examined using a heat map (Java Treeview) red staining indicating higher expression. miRs 136, 743a and 463* were expressed at
consistently higher levels in the spermatogonia samples and the expression of miRs 293, 291a-5p, 294* and 290-5p were expressed at consistently
lower levels in spermatogonia.
doi:10.1371/journal.pone.0035553.g002
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morphological changes and cell migration, indicating Wnt
signalling could have unique roles in addition to directing
spermatogonial stem cell renewal [57]. Knockout of naked cuticle
1 (Nkd1), an antagonist of the canonical Wnt signalling pathway
(controlling novel gene expression), caused sub fertility in male
mice. The elongating spermatid population is reduced in these
mice, indicating a problem in the later stages of spermiogenesis
[58]. Furthermore, elements of the non-canonical Wnt signalling
pathway i.e. Dishevelled1 (Dvl1) (which influences cell morphol-
ogy and migration), are thought to control the morphological
change(s) of spermatids that eventually permit their differentiation
into mature spermatozoa [59]. In addition to their essential role in
germ cell development, Wnt signalling also directs the maturation
of Sertoli cells and their ability to support the process of
spermatogenesis [60]. Wnt signalling is involved in the mainte-
nance of ‘‘stemness’’ in multipotent and pluripotent stem cells
including neural, mammary and embryonic stem cells [61]. As
components of the Wnt signalling pathway such as FZD7 and
FZD4 are disrupted in many cancer types including colon, renal,
brain and breast tumours [62–64], it is believed they promote the
ability of the tumour to proliferate and invade the surrounding
tissue. The multiple potential miRNA targets identified in the Wnt
signalling pathway in our analysis indicates regulation by miRNA
molecules is likely to play a significant role in modifying the Wnt
signalling pathway and in turn germ cell development. By analogy
it is possible that dysregulation of the miRNAs may contribute to
germ cell tumour development.
Within the Wnt signalling pathway (Fig. 5) the expression of
Sox2 and Sox11 was examined and were found to be decreased in
spermatogonial cells when compared to gonocytes (protein and/or
mRNA) (Fig. 4). As described previously, Sox2 is involved in the
maintenance of pluripotency [49–51]. While the role of Sox11 is
not as well defined as that of Sox2, particularly in postnatal life, it
has been implicated in neuron development and differentiation in
the embryo [65]. Sox11 has also been found to be expressed in
multipotent stromal stem cells, and Sox11 knockdown leads to
reduced proliferation and promotes differentiation [66]. In
contrast, knockdown of Sox11 in mantle cell lymphoma cell lines
actually increases cell proliferation and promotes tumorigenesis
when injected into nude mice [67]. Therefore, while it is clear that
Sox11 is involved in the regulation of the cell cycle, its ability to
promote or inhibit cellular proliferation may in fact be influenced
by the specific cellular environment in which it is expressed. In the
case of spermatogonia, the reduction in Sox11 expression may
increase cell proliferation by up regulating the expression of the
downstream target Cyclin D1 (Fig. 5 and 7). Interestingly, this
same protein also appears as a downstream target of the PTEN
signalling cascade, suggesting convergence or cross-talk between
these pathways may be important in driving the differentiation of
gonocytes.
The PTEN tumour suppressor pathway was also predicted to
contain members which were potential targets of differentially
expressed miRNA (Fig. S2 and 6). One of the possible outcomes
from the PTEN signalling pathway is the modification of the cell
cycle via the post translational regulation of Cyclin D1. Cyclin D1
is known to promote cell cycle progression from G1 to S phase
[68], and its expression has previously been shown to occur in
spermatogonia at post natal day 4 when the cell cycle has resumed
[69]. After post natal day 4 in the mouse testis, we propose that
post-translational control of the activity of Cyclin D1 could be
required to fine tune the cell cycle. The seven significantly different
miRNA molecules between gonocytes and spermatogonia identi-
fied in this study have the potential to influence the activity of
Figure 3. Confirmation of miRNA microarray analysis using
qPCR. Total RNA from isolated germ cell populations (five biological
replicates) was reverse transcribed with specific primers and specific
miRNA molecules were amplified by QPCR. The resultant data was
analysed using the 2e-DDT calculation to determine the expression in
spermatogonia relative to gonocytes. A) All the down-regulated miRNA
(miR-293, 291a-5p, 294* and 290-5p (green)) identified by the SAM
analysis in Figure 2 were found to be expressed in spermatogonia at
approximately 20% of the level they were in gonocytes (p,0.0001). B)
All the down-regulated miRNA (miR-136, 743a and 463* (red)) identified
by SAM were found to be expressed at significantly higher levels in
spermatogonia than in gonocytes. miR-136 was up-regulated 2 fold
(p,0.001), miR743a was up-regulated 4 fold (p,0.0001) while miR-463*
was up-regulated 50 fold (p,0.01).
doi:10.1371/journal.pone.0035553.g003
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PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e35553Figure 4. Expression of predicted targets of up and down-regulated miRNA molecules. A) Total RNA from isolated gonocytes and
spermatogonia (three biological replicates) was reverse transcribed before gene specific amplification. The resultant data was analysed using the 2e-
DDT calculation to determine mRNA expression in spermatogonia relative to gonocyte expression. Gene expression of Sox11 (p,0.01) and Sox2
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PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35553Cyclin D1. One down-regulated miRNA molecule (miR-291a-5p)
targets the negative regulator of Cyclin D1 (GSK3) allowing its
expression and therefore limiting the effect of Cyclin D1. At the
same time the positive regulator of Cyclin D1, ERK1/2, is also
theoretically targeted by an up-regulated miRNA molecule (miR-
136), which may result in a reduction of expression to limit the
effect of Cyclin D1 on the cell cycle.
Cyclin D1 has previously been shown to be an indirect target of
miRNA via a different pathway. Using epithelial cells transformed
by c-Myc, Feng et al [70] demonstrated miR-378 was a direct
target of c-Myc. miR-378 in turn cooperates with either RAS or
HER2 to target the cell cycle repressor TOB2 which directly
controls the expression of Cyclin D1 [70]. As Cyclin D1 is
frequently over expressed in testicular germ cell tumours which
have become resistant to cisplatin therapies, we concur with the
(p,0.001), BMPR1a (p,0.01) SMAD4 (P,0.001) was reduced in the spermatogonia. The expression of the other genes examined: PTEN, FZD4, FZD7
and AKT1 did not change between gonocytes and spermatogonia. B) SDS protein extractions of isolated gonocyte and spermatogonia cells were
analysed by SDS-PAGE and immunoblotting [39]. C) The mRNA and protein expression of genes of interest expressed relative to gonocyte expression.
mRNA expression was determined via qPCR (values from A). Densitometry was used to quantify the protein expression between gonocytes and
spermatogonia (n=2). A ratio of the protein of interest to the a TUBULIN control was used to normalise loading. The ratio of spermatogonia to
gonocyte demonstrates the change in protein expression. A value greater than 1 indicates higher expression in the spermatogonia while a value less
than 1 indicates higher expression in gonocytes.
doi:10.1371/journal.pone.0035553.g004
Figure 5. Wnt/b catenin signalling pathway. The Wnt/b catenin signalling pathway was chosen from the pathways identified in the IPA analysis
(Figure S2) for closer examination. The signalling pathway was outlined in IPA and the genes targeted by miRNA molecules are identified on the
pathway alongside their targeting miRNA molecules (red: up-regulated in spermatogonia, green: down-regulated in spermatogonia). Targets
examined for gene and protein expression levels are colour coded according to their expression in gonocytes and spermatogonia, up-regulated
molecules red, unchanged molecules yellow and down-regulated molecules green. In this pathway the expression of AKT, fzd4 and fzd7 was
unchanged. Sox2 and sox11 expression were down-regulated at both the gene and protein level. The target protein Cyclin D1 is identified by blue
highlighting.
doi:10.1371/journal.pone.0035553.g005
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cell cycle transition and limit the cells sensitivity to the
chemotherapy agent [68,71].
The KIT and EBBR2 receptors are frequently up regulated in
testicular germ cell tumours. Both of these receptors activate the
KRAS signalling pathway, which in turn is also commonly up-
regulated in these tumours. KRAS activates both the MAP kinase
pathway as well as the PI3K/AKT pathway to control cell
proliferation and survival [72]. The PI3K/AKT is a key signalling
pathway promoting cell proliferation, survival and migration
which is subject to modulation by several negative regulators such
as PTEN and PI3kip1 [73,74]. Importantly, the ablation of PTEN
is associated with the transformation of CIS cells, the precursor
lesion for seminoma and nonseminoma into invasive cancer [73].
PTEN loss allows these cells to survive and proliferate without the
support of the Sertoli cells, a key step in the neoplastic
development of CIS [73]. In addition, the reduced expression of
PI3kip1 in testicular germ cell tumours is associated with a high
disease relapse rate [74]. PI3K and AKT are activated by GDNF
and have been shown to be key promoters of self- renewal and
survival in spermatogonial stem cells [75] as well as promoting the
proliferation and survival of meiotic germ cells. However, despite
PTEN being expressed in all stages of male germ cells and very
highly expressed in spermatogonia, the PTEN knockout mouse
has normal spermatogenesis, are fertile and have no testicular
tumours, indicating that PTEN may have a functional redundancy
in mice [76]. Knockdown of ETV5 and POU3F1 (oct6), both
transcription factors activated by GDNF, caused apoptosis in
spermatogonial stem cells in part due to the overexpression of
PI3kip1, further indicating the importance of PI3K/AKT
signalling and its regulation in normal spermatogenesis [77]
In this study we identified seven miRNA molecules differentially
expressed between postnatal gonocytes and spermatogonia. The
miRNA molecules down-regulated (miR-293, 291a-5p, 290-5p
Figure 6. The PTEN signalling pathway. The PTEN signalling pathway was chosen from the pathways identified in the IPA analysis (Figure S2) for
closer examination. The signalling pathway was outlined in IPA and the genes targeted by miRNA molecules are identified on the pathway alongside
their targeting miRNA molecules (red unregulated in spermatogonia, green down-regulated in spermatogonia). Targets examined for gene and
protein expression levels are colour coded according to their expression in gonocytes and spermatogonia, up-regulated molecules red, unchanged
molecules yellow and down-regulated molecules green. In the PTEN pathway the expression of PTEN, AKT, ERK and MEK remained unchanged
between gonocytes and spermatogonia while the expression of the growth receptor BMPR1a was significantly reduced in spermatongia when
compared to gonocytes. The target protein Cyclin D1 is identified by blue highlighting.
doi:10.1371/journal.pone.0035553.g006
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PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e35553and 294*) are located in a miRNA cluster previously found to be
involved in the maintenance of pluripotency within stem cells. In
contrast, the up-regulated miRNA molecules in spermatogonia
(miR-136, MiR-743a and miR-463*) have mostly unknown
functions. However, the abundance of predicted targets in the
Wnt/b-catenin signalling pathway and the PTEN signalling which
have previously been found to be important for male fertility
indicates their possible role in maintaining germ cell differentiation
and or pluripotency.
Supporting Information
Figure S1 Top pathways identified by IPA with potential to be
affected by significant miRNA. Individual lists of targets as shown
in supplementary table S5 of significant miRNA species were
analysed by Ingenuity Pathway Analysis (IPA) version 8.8 to
identify the effected pathways. IPA analysis output graphs show
the measure of significance (right tailed Fishers exact test (P value
logged) in the histogram bars while the proportion of targeted
proteins over total proteins in the pathway is shown as a line. A)
The top 15 pathways identified as containing a high number of
targets miR-136. B) The top 15 pathways identified as containing
a high number of targets of miR-463*. C) The top 15 pathways
identified as containing a high number of targets of miR-743a. D)
The top 15 pathways identified as containing a high number of
targets of miR-290-5p. E) The top 15 pathways identified as
containing a high number of targets of miR-293. F) The top 15
pathways identified as containing a high number of targets of miR-
294*. G) The top 15 pathways identified as containing a high
number of targets of miR-291a-5p.
(TIF)
Figure S2 Top pathways identified by IPA with potential to be
affected by significant miRNA. Targets of significant miRNA
molecules were predicted as described in the text (or in materials
and methods) Combined targets of up or down-regulated miRNA
species were then analysed by Ingenuity Pathway Analysis (IPA)
version 8.8 to identify the effected pathways. IPA analysis output
graphs show the measure of significance (right tailed Fishers exact
test (P value logged) in the histogram bars while the proportion of
targeted proteins over total proteins in the pathway is shown as a
line. A) The top 15 pathways identified as containing a high
number of targets of miRNA down-regulated in spermatogonia. B)
The top 15 pathways identified as containing a high number of
targets of miRNA up-regulated in spermatogonia.
(TIF)
Table S1 Antibodies in use and conditions for immunoblots,
immunocytochemistry and immunohistochemistry.
(DOC)
Figure 7. The expression of Cyclin D1 in gonocytes and spermatogonia. A) Total RNA from isolated gonocytes and spermatogonia (three
biological replicates) was reverse transcribed before gene specific amplification. The resultant data was analysed using the 2e-DDT calculation to
determine mRNA expression in spermatogonia relative to gonocyte expression. Cyclin D1 miRNA expression in spermatogonia was found to be 6
times higher than in gonocytes (p,0.0001). B) SDS protein extractions of isolated gonocyte and spermatogonia cells were analysed by SDS-PAGE and
immunoblotting [39]. Densitometry analysis of immunoblots (n=2) indicates that the expression of Cyclin D1 was four times higher in spermatogonia
compared to gonocytes. Immunohistochemistry of Cyclin D1 (red) on day 2 (Figure 7C) and day 8 (Figure 7D) indicates that Cyclin D1 was not
expressed in day 2 testis but was expressed in the spermatogonia cells of day 8 testis.
doi:10.1371/journal.pone.0035553.g007
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ranked according to their expression levels. Total RNA from
highly enriched gonocytes and spermatogonia was labelled and
hybridized to the Illumina mouse miRNA microarray (version 1
revision 2). The data was backgrounds subtracted and normalised
against the mean of (small nuclear RNA) snoRNA 142 and
snoRNA234-1. The miRNA was then ranked according to its
abundance. A) miRNA species ranked according to their
expression in gonocytes. With the most highly expressed miRNA
species appearing first. B) miRNA species ranked according to
their expression in spermatogonia. With the most highly expressed
miRNA species appearing first.
(XLS)
Table S3 miRNA molecules ranked according to their fold
change between gonocytes and spermatogonia. Total RNA from
highly enriched gonocytes and spermatogonia was labelled and
hybridized to the Illumina mouse miRNA microarray (version 1
revision 2). The data was backgrounds subtracted and normalised
against the mean of (small nuclear RNA) snoRNA 142 and
snoRNA234-1. The miRNA was then ranked according to its fold
change between gonocytes and spermatogonia (gonocytes/sper-
matogonia).
(XLS)
Table S4 qPCR primer sequences and annealing temperatures.
Forward and reverse primer sequences (Sigma) used to selectively
amplify the genes of interest with their associated annealing
temperatures. For the miRNA sequences capital letters indicate
the location of locked nucleic acids used to raise the melting
temperature of the primer (GeneWorks, Hindmarsh, SA, Aus-
tralia).
(DOC)
Table S5 Complete list of predicted targets for miRNA
molecules differentially expressed between gonocytes and sper-
matogonia. Targets for the miRNA molecules of interest were
predicted by the feature in the miRWalk database (http://www.
ma.uni-heidelberg.de/apps/zmf/mirwalk/) that allowed simulta-
neous searches of many databases. The databases included
miRanda, MiRDB, MiRWalk, PITA, RNA22, RNAhybrid and
Targetscan. The targets (rows) identified by a program (columns)
are coloured green while the targets not identified by a program
are red. Targets identified four or more of these programs were
added to our list of potential targets that would be examined more
closely. Genes are ranked according to the number of software
programs predicting them as targets. However due to the limited
algorithms able to predict targets of miRNA complementary
strands (*) miRNA* targets were identified using miRWalk and
MiRanda and those targets predicted by both these programs were
examined more closely not colour coded. A) Targets for mmu-
miR-136. B) Targets for mmu-mir-463*. C) Targets for mmu-
miR-743a. D) Targets for mmu-miR-291a-5p. E) Targets for
mmu-miR-293. F) Targets for mmu-miR-294*. G) Targets for
mmu-miR-290-5p.
(XLS)
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